CryoCath Freezor Tachycardia Approval Includes Cryomapping Indication
This article was originally published in The Gray Sheet
Executive Summary
CryoCath says it will pursue an expanded indication for its Freezor cardiac cryoablation system to address epicardial posteroseptal accessory atrioventricular pathways